CONNECTICUT
-
GUESS WATCHES ANNOUNCES PARTNERSHIP WITH DRESS FOR SUCCESS®
NORWALK, Conn., Feb. 28, 2022 /PRNewswire/ -- GUESS Watches announces its partnership with Dress for Success, a global not-for-profit organization that empowers women to achieve economic independence…
-
Pets Adjusting to Post-Pandemic World
MYSTIC, Conn., Feb. 28, 2022 /PRNewswire/ -- Renowned animal Psychic Nancy Mello has been providing much-needed support to pets and families as the world begins to reopen. When millions were forced to…
-
Cigna Announces Significant Increase to Share Repurchase Program and Capital Deployment
BLOOMFIELD, Conn., Feb. 28, 2022 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE: CI) today announced a series of capital deployment priorities designed to enhance shareholder va…
-
Knights of Columbus Makes Pledge to Ukraine, Sets Goal of Initial $2 Million in Aid
NEW HAVEN, Conn., Feb. 25, 2022 /PRNewswire/ -- The Knights of Columbus today announced a commitment of $1 million for immediate distribution to support Ukrainian refugees, including Ukrainian Knights…
-
Terex to Present at the Evercore ISI 14th Annual Industrial Conference
NORWALK, Conn., Feb. 25, 2022 /PRNewswire/ -- Terex Corporation (NYSE: TEX) announced today that company leadership will participate in a fireside chat at the Evercore ISI Industrial Conference. They…
-
BIOHAVEN REPORTS FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND RECENT BUSINESS DEVELOPMENTS
NEW HAVEN, Conn., Feb. 25, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biopharmaceutical company with a portfolio of innovative, late-stage product candidates tar…
-
Biohaven and Pfizer Receive Positive CHMP Opinion for Migraine Treatment
NEW HAVEN, Conn. and NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Prod…
-
Biohaven Acquires Kv7 Ion Channel Platform for the Treatment of Epilepsy and Other Neurologic Disorders From Channel Biosciences, a Subsidiary of Knopp Biosciences
NEW HAVEN, Conn., Feb. 25, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN; the "Company" or "Biohaven") announced today that it has entered into a definitive agreement t…
-
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
NEW HAVEN, Conn., Feb. 25, 2022 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") announced today that it entered into a worldwide license agreement with Bristol M…
-
US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
RIDGEFIELD, Conn. and INDIANAPOLIS, Feb. 24, 2022 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Jardiance® (empagliflozin) 10 mg to reduce the risk of cardiovascular death a…
-
InventHelp Inventor Develops Comfortable Way to Hold a Barbell (CPC-621)
PITTSBURGH, Feb. 24, 2022 /PRNewswire/ -- "I wanted to create a more comfortable way to hold a barbell when performing squats," said an inventor, from Avon, Conn., "so I invented the SQUAT STRAPS. My…
-
Synchrony to Participate in the KBW Fintech Payments Conference
STAMFORD, Conn., Feb. 24, 2022 /PRNewswire/ -- Synchrony (NYSE: SYF) President and Chief Executive Officer, Brian D. Doubles and Executive Vice President and Chief Financial Officer, Brian J. Wenzel,…
-
FDA Grants BI 1015550 Breakthrough Therapy Designation for Idiopathic Pulmonary Fibrosis
RIDGEFIELD, Conn. and INGELHEIM, Germany, Feb. 24, 2022 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation t…
-
Trevi Therapeutics Reports Statistically Significant Result on Interim Analysis from the Ph2 CANAL Trial of Nalbuphine ER in the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis
NEW HAVEN, Conn., Feb. 24, 2022 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI) today announced positive interim analysis results of the Phase 2 Cough And NALbuphine (CANAL) trial of its inves…
-
Virtus Investment Partners Declares Quarterly Cash Dividend on Common Stock
HARTFORD, Conn., Feb. 24, 2022 /PRNewswire/ -- Virtus Investment Partners, Inc. (NASDAQ: VRTS), which operates a multi-boutique asset management business, today announced that its Board of Directors h…
-
Mastercam 2023 Public Beta Released for Global Testing
TOLLAND, Conn., Feb. 23, 2022 /PRNewswire/ -- If you are a currently maintained Mastercam customer, you can now participate in the Public Beta Program for Mastercam 2023. Manufacturers all over the wo…
-
Ciox Health Partners with Diameter Health to Accelerate Its Digital Network Strategy
ALPHARETTA, Ga. and FARMINGTON, Conn., Feb. 23, 2022 /PRNewswire/ -- Ciox Health®, a Datavant company, today announced a partnership with
-
Cigna Corporation Announces Appearance at the Barclays Global Healthcare Conference
BLOOMFIELD, Conn., Feb. 23, 2022 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE:CI) announced today that Brian Evanko, executive vice president and chief financial officer, wil…
-
Tronox Declares Quarterly Dividend
STAMFORD, Conn., Feb. 23, 2022 /PRNewswire/ -- Tronox Holdings plc (NYSE:TROX), the world's leading integrated manufacturer of titanium dioxide pigment, announced today that its Board of Directors dec…
-
Tronox Announces Launch of Incremental Term Loan and Redemption of 6.5% Senior Secured Notes due 2025
STAMFORD, Conn., Feb. 23, 2022 /PRNewswire/ -- Tronox Holdings plc (NYSE: TROX; the "Company"), the world's leading integrated manufacturer of titanium dioxide pigment, today announced the launch of a…